Eli Lilly and Co. (LLY) announced that the U.S. Food and Drug Administration has approved Omvoh (mirikizumab-mrkz) for the treatment ...

The expected boost from the Gazprom arbitral award will be reflected in OMV’s Gas Marketing & Power unit’s results.

UBS analyst Joshua Stone maintained a Buy rating on OMV AG (OMV – Research Report) today and set a price target of €47.00. The company’s shares ...